Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating the wheezing infant.

Ronina A Covar1, Joseph D Spahn

  • 1The Ira J. and Jacqueline Neimark Laboratory of Clinical Pharmacology and the Division of Allergy and Clinical Immunology, Department of Pediatrics, 1400 Jackson Street (A-303) Denver CO 80206, USA. covarr@njc.org

Pediatric Clinics of North America
|August 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study.

Journal of asthma and allergy·2026
Same author

Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps.

Clinical and experimental immunology·2025
Same author

Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps.

Advances in therapy·2025
Same author

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.

Advances in therapy·2024
Same author

Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023
Same author

Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review.

Journal of asthma and allergy·2023
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Managing asthma in young children presents unique challenges. Early intervention with controller therapy may alter disease course, but criteria for identifying suitable patients require further research.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Management
  • Childhood Respiratory Diseases

Background:

  • Asthma management in infants and young children is complex due to age-specific challenges.
  • Diagnosing asthma in this population is difficult due to limitations in objective lung function and inflammation measures.
  • Identifying children who benefit from early controller therapy is crucial for potentially altering disease trajectory.

Purpose of the Study:

  • To highlight the challenges in diagnosing and managing asthma in infants and young children.
  • To emphasize the need for research into early intervention strategies for infantile asthma.
  • To identify key areas requiring further investigation in pediatric asthma pharmacotherapy.

Main Methods:

  • The abstract discusses the diagnostic and therapeutic challenges based on existing knowledge.

Related Experiment Videos

  • It calls for large prospective studies to evaluate early pharmacologic interventions.
  • It reviews the current limitations in approved medications and the need for long-term drug evaluations.

    • Main Results:

    • There is a lack of established criteria to identify infants and young children who would benefit from early controller therapy.
    • Current research is insufficient to guide the optimal use of medications, delivery methods, and monitoring for infantile asthma.
    • Long-term studies on approved medications like inhaled glucocorticoids, long-acting beta-agonists (LABAs), and leukotriene modifiers in young children are lacking.

    Conclusions:

    • Further large-scale prospective studies are essential to determine the impact of early pharmacologic intervention on the natural history of infantile asthma.
    • More research is needed to establish criteria for identifying patients likely to benefit from early controller therapy.
    • Investigation into appropriate medications, delivery methods, and monitoring strategies for pediatric asthma is critical.